Filed: 5/7/2026ACC: 0001193125-26-210525
📋 What this filing means
SANOFI filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $335.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$335.96M
Total AUM (reported)
28.52M
Total Shares
Allocation by class
COM$236.48M70.4%
COM NEW$56.01M16.7%
SPONSORED ADS$29.19M8.7%
CLASS A COM$14.27M4.2%
Portfolio Concentration
Top 3$239.49M71.3%
4–10$96.47M28.7%
Top 3 weight
71.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.52M
Sole
Full voting authority
28.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings9
Rows:
MeiraGTx Holdings plc
SOLEShares12.20M
TypeSH
Market value$105.63M
31.44%
Sole
12.20M
Shared
0.00
None
0.00
Inhibrx Biosciences, Inc.
SOLEShares1.16M
TypeSH
Market value$77.85M
23.17%
Sole
1.16M
Shared
0.00
None
0.00
Novavax
SOLEShares6.88M
TypeSH
Market value$56.01M
16.67%
Sole
6.88M
Shared
0.00
None
0.00
AnaptysBio
SOLEShares821.92K
TypeSH
Market value$30.38M
9.04%
Sole
821.92K
Shared
0.00
None
0.00
Agomab Therapeutics NV
SOLEShares2.78M
TypeSH
Market value$29.19M
8.69%
Sole
2.78M
Shared
0.00
None
0.00
MapLight Therapeutics Inc.
SOLEShares912.04K
TypeSH
Market value$18.54M
5.52%
Sole
912.04K
Shared
0.00
None
0.00
Immuneering Corp
SOLEShares2.71M
TypeSH
Market value$14.27M
4.25%
Sole
2.71M
Shared
0.00
None
0.00
Eledon
SOLEShares814.98K
TypeSH
Market value$2.51M
0.75%
Sole
814.98K
Shared
0.00
None
0.00
Q32 Bio Inc.
SOLEShares244.08K
TypeSH
Market value$1.57M
0.47%
Sole
244.08K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $105.63M 31.44% | 12.20M | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $77.85M 23.17% | 1.16M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $56.01M 16.67% | 6.88M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $30.38M 9.04% | 821.92K | 0.00 | 0.00 |
Agomab Therapeutics NVSOLE | SPONSORED ADS | 2.78M | SH | $29.19M 8.69% | 2.78M | 0.00 | 0.00 |
MapLight Therapeutics Inc.SOLE | COM | 912.04K | SH | $18.54M 5.52% | 912.04K | 0.00 | 0.00 |
Immuneering CorpSOLE | CLASS A COM | 2.71M | SH | $14.27M 4.25% | 2.71M | 0.00 | 0.00 |
EledonSOLE | COM | 814.98K | SH | $2.51M 0.75% | 814.98K | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $1.57M 0.47% | 244.08K | 0.00 | 0.00 |